Additionally, evidence shows that the administration of Gln inhibits HMGB1 through increased expression of heat shock protein (HSP) 70 and, consequently, reduces lung damage in sepsis-induced lung injury [41]. The gene discussed is HMGB1; the disease is Sepsis.